Linked Data API

Show Search Form

Search Results

1646476
star this property human indexable true more like this
star this property published true more like this
star this property registered interest false more like this
star this property answer date less than 2023-06-26more like thismore than 2023-06-26
star this property date less than 2023-06-21more like thismore than 2023-06-21
star this property date tabled less than 2023-06-21more like thismore than 2023-06-21
star this property ddp created remove filter
star this property answering body
Department of Health and Social Care more like this
star this property question status Tabled more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property ddp modified
less than 2023-06-21T20:25:41.676Zmore like thismore than 2023-06-21T20:25:41.676Z
less than 2023-06-30T11:51:14.071Zmore like thismore than 2023-06-30T11:51:14.071Z
star this property hansard heading Radiotherapy more like this
unstar this property house id 1 more like this
star this property identifier 190613 more like this
star this property legislature
25259
star this property parliament number 58 more like this
star this property question first answered
less than 2023-06-30T11:19:32.81Zmore like thismore than 2023-06-30T11:19:32.81Z
star this property question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of regional variations in the provision of molecular radiotherapy. more like this
star this property session
2022/23 more like this
star this property session number 3 more like this
star this property tabling member constituency Mid Derbyshire more like this
star this property tabling member printed
Mrs Pauline Latham more like this
star this property title House of Commons Tabled Parliamentary Question 2022/23 190613 more like this
star this property type
WrittenParliamentaryQuestion
star this property uin 190613 more like this
star this property version 1 more like this
star this property written parliamentary question type Ordinary more like this
star this property answer
answer
unstar this property answer text <p>Molecular radiotherapy is currently commissioned alongside brachytherapy via a national service specification. There are currently 38 trusts in England that are commissioned to deliver these services however, given the spectrum of treatments available under this service specification, there is some variation in what each provider offers.</p><p>For this reason, NHS England is developing a standalone molecular radiotherapy service specification. This will clarify the service model and review demand and access arrangements. The service specification will also take into account any future developments in treatment technologies and recommendations made by the National Institute for Health and Care Excellence.</p> more like this
star this property creator
4025
star this property label Biography information for Mrs Pauline Latham more like this
star this property publisher 25259
star this property tabling member
4025
star this property label Biography information for Mrs Pauline Latham remove filter